Cbg Synthesis Pathways

CBG synthesis pathways refer to the biochemical mechanisms through which cannabis plants produce cannabigerol (CBG), the non-acidic precursor from which most other major cannabinoids derive. CBG-dominant chemotypes result from genetic and enzymatic variations that either slow conversion of CBG to downstream compounds (CBD, THC) or enhance CBG accumulation before conversion occurs. These pathways are controlled by multiple genes, including those encoding key synthase enzymes and regulatory factors that determine cannabinoid ratios. Understanding CBG pathways is critical for breeders seeking to stabilize CBG-rich cultivars or create novel cannabinoid profiles. Research into CBG synthesis has revealed that certain lineages and breeding populations carry allelic variants that naturally suppress downstream enzymatic activity, preserving higher CBG percentages.

Breeders working with CBG-rich genetics must select for plants that maintain enzymatic equilibrium—either expressing lower synthase activity converting CBG forward, or possessing mutations that prevent complete conversion. Stabilizing CBG-dominant lines requires multiple generations of selection and crosses to homozygous or favorable heterozygous states, as CBG expression can be polygenic and envi